Literature DB >> 10607931

Orally administered, insulin-loaded amidated pectin hydrogel beads sustain plasma concentrations of insulin in streptozotocin-diabetic rats.

C T Musabayane1, O Munjeri, P Bwititi, E E Osim.   

Abstract

We report successful oral administration of insulin entrapped in amidated pectin hydrogel beads in streptozotocin (STZ)-diabetic rats, with a concomitant reduction in plasma glucose concentration. The pectin-insulin (PI) beads were prepared by the gelation of humilin-pectin solutions in the presence of calcium. Separate groups of STZ-diabetic rats were orally administered two PI beads (30 micrograms insulin) once or twice daily or three beads (46 micrograms) once daily for 2 weeks. Control non-diabetic and STZ-diabetic rats were orally administered pectin hydrogel drug-free beads. By comparison with control non-diabetic rats, untreated STZ-diabetic rats exhibited significantly low plasma insulin concentration (0.32+/-0. 03 ng/ml, n=6, compared with 2.60+/-0.44 ng/ml in controls, n=6) and increased plasma glucose concentrations (25.84+/-1.44 mmol/l compared with 10.72+/- 0.52 mmol/l in controls). Administration of two PI beads twice daily (60 micrograms active insulin) or three beads (46 micrograms) once a day to STZ-diabetic rats increased plasma insulin concentrations (0.89+/-0.09 ng/ml and 1.85+/- 0.26 ng/ml, respectively), with a concomitant reduction in plasma glucose concentration (15.45+/-1.63 mmol/l and 10.56+/-0.26 mmol/l, respectively). However, a single dose of PI beads (30 micrograms) did not affect plasma insulin concentrations, although plasma glucose concentrations (17.82+/-2.98 mmol/l) were significantly reduced compared with those in untreated STZ-diabetic rats. Pharmacokinetic parameters in STZ-diabetic rats show that the orally administered PI beads (30 micrograms insulin) were more effective in sustaining plasma insulin concentrations than was s.c. insulin (30 micrograms). The data from this study suggest that this insulin-loaded amidated pectin hydrogel bead formulation not only produces sustained release of insulin, but may also reduce plasma glucose concentration in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10607931     DOI: 10.1677/joe.0.1640001

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Transdermal delivery of insulin by amidated pectin hydrogel matrix patch in streptozotocin-induced diabetic rats: effects on some selected metabolic parameters.

Authors:  Silindile I Hadebe; Phikelelani S Ngubane; Metse R Serumula; Cephas T Musabayane
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

2.  A Dioxidovanadium Complex cis-[VO2 (obz) py] Attenuates Hyperglycemia in Streptozotocin (STZ)-Induced Diabetic Male Sprague-Dawley Rats via Increased GLUT4 and Glycogen Synthase Expression in the Skeletal Muscle.

Authors:  Bonisiwe Mbatha; Andile Khathi; Ntethelelo Sibiya; Irvin Booysen; Phikelelani Ngubane
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-31       Impact factor: 2.629

3.  Cardio-protective effects of a dioxidovanadium(V) complex in male sprague-dawley rats with streptozotocin-induced diabetes.

Authors:  Bonisiwe Mbatha; Andile Khathi; Ntethelelo Sibiya; Irvin Booysen; Patrick Mangundu; Phikelelani Ngubane
Journal:  Biometals       Date:  2020-11-18       Impact factor: 2.949

Review 4.  Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes.

Authors:  Garima Sharma; Ashish Ranjan Sharma; Ju-Suk Nam; George Priya C Doss; Sang-Soo Lee; Chiranjib Chakraborty
Journal:  J Nanobiotechnology       Date:  2015-10-24       Impact factor: 10.435

5.  Colon targeted beads loaded with pterostilbene: Formulation, optimization, characterization and in vivo evaluation.

Authors:  Mudassir Ansari; Bhakti Sadarani; Anuradha Majumdar
Journal:  Saudi Pharm J       Date:  2018-07-20       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.